US Broker Ratings

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Unveiling a 74% Potential Upside in the Biotech Sector

Bicara Therapeutics Inc. (NASDAQ: BCAX) is making waves in the biotech sector with a compelling investment narrative. With a market capitalization of approximately $920.34 million, this..

Mind Medicine Inc. (MNMD) Stock Analysis: Exploring Potential Upside in a Transformative Biotech

Mind Medicine (MindMed) Inc. (MNMD), a pioneering name in the biotechnology landscape, is increasingly capturing the attention of investors keen on exploring the burgeoning field of..

Evolus, Inc. (EOLS) Stock Analysis: A 237% Potential Upside in the Healthcare Sector

Evolus, Inc. (NASDAQ: EOLS) is capturing investor attention with its remarkable potential upside of 237.79%, as highlighted by recent analyst ratings. Specializing in the performance beauty..

iRadimed Corporation (IRMD) Stock Analysis: A Promising 17% Upside in the Medical Devices Industry

For investors seeking opportunities in the healthcare sector, iRadimed Corporation (NASDAQ: IRMD) stands out as a promising option. As a notable player in the medical devices..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Growth with Caution Amid Potential Downside

Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, operates at the intersection of animal health and mineral nutrition. With its headquarters..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Biotech Gem with 279% Potential Upside

LENZ Therapeutics, Inc. (NASDAQ: LENZ) has captured the attention of investors with its promising focus on improving vision through innovative therapies. Situated in the dynamic biotechnology..

STAAR Surgical (STAA) Stock Report: Navigating a 11.84% Potential Upside Amidst Volatile Metrics

STAAR Surgical Company (NASDAQ: STAA), a notable player in the medical instruments and supplies industry, is capturing investor attention with a potential upside of 11.84%. Based..

Zymeworks Inc. (ZYME) Stock Analysis: A High Upside Prospect with Promising Biotech Innovations

Zymeworks Inc. (NASDAQ: ZYME) is gaining attention in the biotech sector with a market cap of $1.81 billion. The company, which is headquartered in Middletown, Delaware,..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Evaluating a Potential 46.86% Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, has recently caught the attention of investors with a notable potential upside of 46.86%...

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 38.57% Upside Potential

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, specifically in medical devices, is drawing investor attention with its compelling growth potential. Headquartered..

CureVac N.V. (CVAC) Investor Outlook: Analyzing the Biotech’s Future Amid Major Acquisition

CureVac N.V. (NASDAQ: CVAC), a prominent player in the biotechnology sector, has recently attracted significant attention due to its acquisition by BioNTech SE. With a market..

Immatics N.V. (IMTX) Stock Analysis: Potential 91% Upside Amid Strong Buy Ratings

Immatics N.V. (NASDAQ: IMTX), a biotechnology frontrunner in the healthcare sector, is capturing investor attention with its ambitious pipeline of cancer immunotherapies. Headquartered in Tübingen, Germany,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges in the Medical Device Sector

Avanos Medical, Inc. (NYSE: AVNS) is a player in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of $672.61 million,..

Nurix Therapeutics, Inc. (NRIX): Biotechnology Innovator with 86% Potential Upside

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is capturing attention in the biotechnology sector, primarily due to its promising drug development pipeline and a potential upside of 86.22%,..

Cronos Group Inc. (CRON): Investor Outlook on a Cannabis Pioneer with 47% Revenue Growth

Cronos Group Inc. (NASDAQ: CRON) is a name that resonates with many investors interested in the burgeoning cannabis market. As a key player in the healthcare..

Butterfly Network, Inc. (BFLY) Stock Analysis: Innovative Medical Devices with a Potential 8.40% Upside

For investors seeking to tap into the burgeoning medical devices sector, Butterfly Network, Inc. (NYSE: BFLY) presents an intriguing opportunity. With its market cap sitting at..

Embecta Corp. (EMBC) Stock Analysis: Attractive Dividend Yield and Significant Upside Potential Beckon Investors

Embecta Corp. (EMBC), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry. The company is renowned for its diabetes care solutions,..

Zevra Therapeutics, Inc. (ZVRA) Investor Outlook: Uncovering a Potential 148% Upside in the Biotech Sector

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has been turning heads in the biotechnology sector with its focus on rare diseases and promising product pipeline. With a market..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A Potential 233% Upside in the Healthcare Sector

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company, is capturing investor attention with its substantial potential upside of 233.33%, making it a noteworthy candidate for those..

HealthStream, Inc. (HSTM) Stock Report: Exploring a 42.99% Potential Upside

HealthStream, Inc. (HSTM), a key player in the healthcare sector specializing in health information services, offers a compelling investment opportunity with an estimated potential upside of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds